Association of sFRP4, a novel serum biomarker, in patients with Endometriosis

article OA: green CC0

Abstract

Introduction: An inflammation mediator, called secreted frizzled-related protein 4 (sFRP4), is closely associated with endometrial tissue. The purpose of the study was to test the feasibility of sFRP4 as a non-invasive diagnostic biomarker in different grades of endometriosis and to study the presence of sFRP4 in the peritoneal fluid of these patients. Aims and objectives: To correlate serum & peritoneal fluid (PF) levels of sFRP4 in women with endometriosis. Materials and methods: A hospital based cross-sectional case control study was carried out on women who were admitted for operative laparoscopy for the diagnosis of endometriosis. Based on their grading according to the revised American Society of Reproductive Medicine (rASRM), 22 patients with endometriosis aged 18– 45 years and 21 age matched healthy controls were included in the study. sFRP4 was estimated by ELISA method. Results: Mean of serum and saline wash of POD levels of sFRP4 in endometriosis patients was found to be 8017.0 ± 2577.8 pg/ml &3718.9 ± 1650.8 pg/ml, respectively & that in serum of controls was 3871.0 ± 2077.8 pg/ml. Serum sFRP4 levels of cases were significantly elevated when compared to controls (p<0.0001). Total serum sFRP4 levels were positively correlated with saline wash of POD sFRP4 (r=0.743, p<0.001). Conclusion: An increase in serum sFRP4, correlates with peritoneal fluid concentrations, and accompanies with increasing grades of endometriosis.

My notes (saved in your browser only)

Outcome instruments

rASRM

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:02:17.246033+00:00
License: CC0 · commercial use OK